🇯🇵 Guselkumab (GUS) in Japan

Guselkumab (GUS) (Guselkumab (GUS)) regulatory status in Japan.

Marketing authorisation

PMDA

Application: Tremfya
Local brand name: Tremfya
Status: approved

Guselkumab (GUS) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

🇪🇺 European Union

Frequently asked questions

Is Guselkumab (GUS) approved in Japan?

Yes. PMDA has authorised it.

Who is the marketing authorisation holder for Guselkumab (GUS) in Japan?

Second Affiliated Hospital, School of Medicine, Zhejiang University is the originator. The local marketing authorisation holder may differ — check the official source linked above.